Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study.

Skoog Ståhlgren G, Tyrstrup M, Edlund C, Giske CG, Mölstad S, Norman C, Rystedt K, Sundvall PD, Hedin K.

BMJ. 2019 Oct 4;367:l5337. doi: 10.1136/bmj.l5337.

2.

[Time to fill the knowledge gaps about the use of antibiotics in practice].

Edlund C.

Lakartidningen. 2017 Mar 21;114. pii: EHY9. Swedish. No abstract available.

3.

A randomized controlled study of 5 and 10 days treatment with phenoxymethylpenicillin for pharyngotonsillitis caused by streptococcus group A - a protocol study.

Skoog G, Edlund C, Giske CG, Mölstad S, Norman C, Sundvall PD, Hedin K.

BMC Infect Dis. 2016 Sep 13;16:484. doi: 10.1186/s12879-016-1813-7.

4.

[New recommendations for antibiotics in dental care also relevant for physicians].

Edlund C, Aronsson B.

Lakartidningen. 2014 Feb 26-Mar 11;111(9-10):406. Swedish. No abstract available.

PMID:
24707559
5.

Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).

Hanberger H, Edlund C, Furebring M, G Giske C, Melhus A, Nilsson LE, Petersson J, Sjölin J, Ternhag A, Werner M, Eliasson E; Swedish Reference Group for Antibiotics.

Scand J Infect Dis. 2013 Mar;45(3):161-75. doi: 10.3109/00365548.2012.747694. Epub 2012 Dec 28. Review.

PMID:
23270477
6.

[Metronidazole cream approved for nonprescription use].

Edlund C, Rastad JA, Cars O, Erntell M.

Lakartidningen. 2011 Oct 5-11;108(40):1976. Swedish. No abstract available.

PMID:
22111242
7.

The global need for effective antibiotics-a summary of plenary presentations.

Alvan G, Edlund C, Heddini A.

Drug Resist Updat. 2011 Apr;14(2):70-6. doi: 10.1016/j.drup.2011.01.007. Epub 2011 Mar 26. Review.

PMID:
21440487
8.

Long-term impacts of antibiotic exposure on the human intestinal microbiota.

Jernberg C, Löfmark S, Edlund C, Jansson JK.

Microbiology. 2010 Nov;156(Pt 11):3216-23. doi: 10.1099/mic.0.040618-0. Epub 2010 Aug 12. Review.

PMID:
20705661
9.

Metronidazole is still the drug of choice for treatment of anaerobic infections.

Löfmark S, Edlund C, Nord CE.

Clin Infect Dis. 2010 Jan 1;50 Suppl 1:S16-23. doi: 10.1086/647939. Review.

PMID:
20067388
10.

Prolonged impact of a one-week course of clindamycin on Enterococcus spp. in human normal microbiota.

Lindgren M, Lofmark S, Edlund C, Huovinen P, Jalava J.

Scand J Infect Dis. 2009;41(3):215-9. doi: 10.1080/00365540802651897.

PMID:
19107676
11.

Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine.

Löfmark S, Jernberg C, Billström H, Andersson DI, Edlund C.

Anaerobe. 2008 Jun;14(3):157-60. doi: 10.1016/j.anaerobe.2008.02.003. Epub 2008 Mar 12.

PMID:
18434218
12.

Long-term ecological impacts of antibiotic administration on the human intestinal microbiota.

Jernberg C, Löfmark S, Edlund C, Jansson JK.

ISME J. 2007 May;1(1):56-66. Erratum in: ISME J. 2013 Feb;7(2):456.

PMID:
18043614
13.
14.

Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin.

Nyberg SD, Osterblad M, Hakanen AJ, Löfmark S, Edlund C, Huovinen P, Jalava J.

Scand J Infect Dis. 2007;39(6-7):514-20.

PMID:
17577812
15.

Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes.

Löfmark S, Jernberg C, Jansson JK, Edlund C.

J Antimicrob Chemother. 2006 Dec;58(6):1160-7. Epub 2006 Oct 17.

PMID:
17046967
16.

ICU stay promotes enrichment and dissemination of multiresistant coagulase-negative staphylococcal strains.

Agvald-Ohman C, Lund B, Hjelmqvist H, Hedin G, Struwe J, Edlund C.

Scand J Infect Dis. 2006;38(6-7):441-7.

PMID:
16798690
17.

Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries.

Oprica C, Löfmark S, Lund B, Edlund C, Emtestam L, Nord CE.

Anaerobe. 2005 Jun;11(3):137-43. Epub 2005 Mar 5.

PMID:
16701544
18.

Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates.

Löfmark S, Fang H, Hedberg M, Edlund C.

Antimicrob Agents Chemother. 2005 Mar;49(3):1253-6.

20.
22.

Antibiotic properties of novel synthetic temporin A analogs and a cecropin A-temporin A hybrid peptide.

Wade D, Flock JI, Edlund C, Löfving-Arvholm I, Sällberg M, Bergman T, Silveira A, Unson C, Rollins-Smith L, Silberring J, Richardson M, Kuusela P, Lankinen H.

Protein Pept Lett. 2002 Dec;9(6):533-43.

PMID:
12553862
23.

Selection of cefoxitin-resistant bacteroides thetaiotaomicron mutants and mechanisms involved in beta-lactam resistance.

Fang H, Edlund C, Nord CE, Hedberg M.

Clin Infect Dis. 2002 Sep 1;35(Suppl 1):S47-53.

PMID:
12173108
24.

Gastrointestinal transit survival of an Enterococcus faecium probiotic strain administered with or without vancomycin.

Lund B, Adamsson I, Edlund C.

Int J Food Microbiol. 2002 Jul 25;77(1-2):109-15.

PMID:
12076027
25.
26.

New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group.

Fang H, Edlund C, Hedberg M, Nord CE.

Int J Antimicrob Agents. 2002 May;19(5):361-70. Review.

PMID:
12007843
27.

Antianaerobic activity of a cecropin---melittin peptide.

Edlund C, Hedberg M, Engström A, Flock JI, Wade D.

Clin Microbiol Infect. 1998 Apr;4(4):181-185.

28.

In vitro activity of linezolid and eperezolid against anaerobic bacteria.

Edlund C, Oh H, Nord CE.

Clin Microbiol Infect. 1999 Jan;5(1):51-53. No abstract available.

Supplemental Content

Loading ...
Support Center